Table 3 TCR Vβ expansions in BAL and PBMC indicating CD4 ⁺ or CD8 ⁺ expansions and patient and control id with HLA DRB1 type

Vb1

CD4

P 6

4, 8

CD8

P 1

4, 15

CD8

P 4

CD8

P 5

13, 14

CD8

P 9

3, 16

CD8

Ctrl 9

4, 15

Vb2

CD4

P 1

4, 15

CD4

P 5

13, 14

CD8

P 6

4, 8

CD4

Ctrl 8

12, 15

CD8

Ctrl 9

4, 15

Vb5.1

CD4

P 13

15

CD 4

P 15

4, 8

Vb5.2

CD8

Ctrl 6

Vb7.1

CD8

P 14

4, 7

Vb7.2

CD8

P 2

3

CD4

P 7

4, 15

Vb8

CD8

P 13

15

CD4

P 3

1, 3

CD8

P 14

4, 7

CD4

P 7

4, 15

Vb11

CD8

P 13

15

CD8

P 3

1, 3

P 4

P 4

Vb12

CD4

P 8

1, 13

CD4

CD8

P 5

13, 14

CD4

P 15

4, 8

CD4

P 6

4, 8

CD8

P 1

4, 15

CD8

P 1

4, 15

CD8

P 6

4, 8

CD8

P 2

CD8

P 12

4, 15

CD4

Ctrl 2

CD4

Ctrl 5

CD8

Ctrl 1

CD8

Ctrl 2

CD8

Ctrl 3

CD8

Ctrl 5

CD8

Ctrl 6

Vb13.1

CD4

P 13

15

CD4

P 3

1, 3

CD4

Ctrl 9

4, 15

CD8

P 3

1, 3

P 5

13, 14

Vb13.2

CD4

P 13

15

CD8

P 13

15

15

CD8

P 6

4, 8

CD4

Ctrl 8

CD4

Ctrl 9

4, 15

Vb13.6

CD8

P 13

15

CD4

Ctrl 8

12, 15

CD8

Ctrl 7

7, 16

CD8

Ctrl 8

12, 15

Vb16

CD4

P 3

1, 3

CD8

P 1

4, 15

CD4

P 15

4, 8

CD8

P 2

3

CD8

P 6

4, 8

CD8

P 5

13, 14

CD8

P 12

4, 15

CD8

P 11

13, 15

CD8

P 13

15

CD4

Ctrl 2

CD4

Ctrl 7

7, 16

CD4

Ctrl 4

CD8

Ctrl 7

7, 16

CD8

Ctrl 2

CD8

Ctrl 8

12, 15

CD8

Ctrl 3

Ctrl 4

Ctrl 9

4, 15

Vb17

CD4

P 15

4, 8

CD8

Ctrl 5

CD8

Ctrl 8

12, 15

Vb18

CD4

P 12

4, 15

Vb20

CD4

P 1

P 1

4, 15

CD4

P 13

P 13

15

Vb21.3

CD8

P 2

3

Vb22

CD4

P 2

3

CD4

P 3

1, 3

CD4

P 9

3, 16

CD8

P 4

CD8

P 15

4, 8

Vb23

CD4

P 3

1, 3

CD8

P 3

1, 3

CD4

Ctrl 9

4, 15

BAL

PBMC

a

CD4

CD8

CD4

CD8

Patients

16/271 (5.9%)

21/240 (8.7%)

9/276 (3.3%)

12/263 (4.6%)

Controls

6/63 (9.5%)

6/63 (9.5%)

5/187 (2.7%)

11/181 (6.1%)